Clinical predictors of long-term efficacy of first-line pembrolizumab monotherapy in non-small cell lung cancer (NSCLC): an interim analysis of real-world data

被引：0

作者：

Younan, Helen-Cara ^{[1
]}

Zhang, Shuai ^{[2
]}

Monroy, Maria ^{[3
]}

Almusarhed, Manar ^{[4
]}

Julve, Max ^{[5
]}

Roy, Debashree ^{[4
]}

Toghey, Sopozme ^{[2
]}

Ahmed, Zartaj ^{[2
]}

Slater, Stephanie ^{[5
]}

Altharwane, Shaymaa ^{[4
]}

Giorgiou, Alex ^{[3
]}

Ghosh, Sharmistha ^{[3
]}

Gennatas, Spyridon ^{[3
]}

Karapanagiotou, Eleni ^{[3
]}

Montes, Ana ^{[3
]}

Pintus, Elias ^{[3
]}

Spicer, James ^{[3
]}

Shah, Riyaz ^{[2
]}

Ahmed, Samreen ^{[4
]}

Newsom-Davis, Tom ^{[5
]}

Mohammed, Waleed ^{[1
]}

Power, Danielle ^{[1
]}

Evans, Joanne ^{[1
]}

Hatcher, Olivia ^{[1
]}

Lakhani, Amish ^{[1
]}

Samani, Amit ^{[1
]}

Josephs, Debra ^{[3
]}

机构：

[1] Imperial Coll Healthcare NHS Trust, London, England

[2] Maidstone & Tunbridge Wells NHS Trust, Tunbridge Wells, Kent, England

[3] Guys & St Thomas NHS Fdn Trust, London, England

[4] Univ Hosp Leicester NHS Trust, Leicester, Leics, England

[5] Chelsea & Westminster Hosp NHS Fdn Trust, London, England

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S32 / S32

页数：1